« September 2011 | Main | December 2011 »

2 posts from October 2011

10/25/2011

The Evolution of Leukemia Treatment

Evolution of Leukemia Treatment - Infographic

More than 250,000 people are living with, or in remission from, leukemia in the United States today. That means that approximately every four minutes, someone else is diagnosed with the disease. Those struggling to overcome leukemia come from all walks of life—in fact, non-Hodgkin’s lymphoma is the fifth most common cancer in the United States, affecting people of both genders and of all ages. Despite this fact, adults are diagnosed with leukemia 10 times more often than children, and the median age at diagnosis is 66 years old.

Treatments for leukemia have come a long way since the early 1900s when the primary therapy for the disease was arsenic. This evolution can be seen as a function of the way physicians and researchers have come to understand the disease, and early in the 20th century, four types of leukemia were classified: chronic lymphocytic leukemia, chronic myelogenous leukemia, acute lymphocytic leukemia, and erythroleukemia. It was in the 1920s that doctors understood that radiation, which was then used as a standard treatment for leukemia, could be a cause of the disease as well as a cure.

Today many people both young and old are able to successfully fight the disease with modern treatments like chemotherapy and bone marrow transplants, and research is being done all the time for effective and safe new ways of helping people win the battle with leukemia.

Embed this image on your site:

10/13/2011

LRF Meet the Doctor Series
Julie Vose, MD

Julie Vose, MDI am looking forward to being the guest physician speaking at the Lymphoma Research Foundation’s Meet the Doctor series where I will be giving an update on lymphoma treatment options. The meet the doctor series allows patients to have close interactions with physicians who are specialists in their area of care and research. It gives them opportunities to interact with others in a similar situation and ask questions.

The program includes a general Lymphoma overview, an update on lymphoma treatment and current research. I think it is important that people know there are about 100 different types of lymphomas and the diagnosis and treatment need to be personalized for each patient and is very specialized based on many factors.

This spring new research illustrated that some patients with transformed lymphoma showed remarkable response to lenalidomide, an oral drug with few side effects. I believe strongly in the importance of lymphoma research and clinical trials conducted to discover new lymphoma treatments. At any given time, The University of Nebraska Medical Center has about 20 to 25 clinical trials open for various types of lymphomas and we gather information on all patients to help future patients.

I encourage my patients to join clinical trials during all phases. Clinical trials examine the side effects, effectiveness and outcomes of new treatments compared to standard of care agents.

Event Details
Tuesday, Oct. 18
6 p.m.
Michael F. Sorrell Center for Health Science Education
4201 Emile Street
Room: MSC 4053 (Seminar)
Registration
Phone: 800-500-9976
E-mail: mspellman@lymphoma.org
Web: lymphoma.org/askthedoctor

Julie Vose, MD
Hematology Oncology
The Nebraska Medical Center

Neumann M. and Mildred E. Harris Professor, Chief, Division of Hematology Oncology and Professor of Medicine, University of Nebraska Medical Center

Call 800-922-0000 to make an appointment with Dr. Julie Vose. For clinic location and hours use the Find a Physician link.

Share